136834-21-4

Basic information

• Product Name: Adenosine, N-benzoyl-5'-O-[bis(4-Methoxyphenyl)phenylMethyl]-2'-deoxy-2'-fluoro-
• Synonyms: Adenosine, N-benzoyl-5'-O-[bis(4-Methoxyphenyl)phenylMethyl]-2'-deoxy-2'-fluoro-;N6-benzoyl-2'-deoxy-2'-fluoro-5'-O-(4,4'-dimethoxytrityl)adenosine;N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoroadenosine;5'-O-DMT-N6-BENZOYL-2'-FLUORO-2'-DEOXYADENOSINE
• CAS NO: 136834-21-4
• Molecular Formula: C₃₈H₃₄FN₅O₆
• Molecular Weight: 675.7048632
• Mol File: 136834-21-4.mol
• Article Data: 15

Chemical Properties

• Appearance: /
• Density: 1.35±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 7.87±0.43(Predicted)
• CAS DataBase Reference: Adenosine, N-benzoyl-5'-O-[bis(4-Methoxyphenyl)phenylMethyl]-2'-deoxy-2'-fluoro-(CAS DataBase Reference)
• NIST Chemistry Reference: Adenosine, N-benzoyl-5'-O-[bis(4-Methoxyphenyl)phenylMethyl]-2'-deoxy-2'-fluoro-(136834-21-4)
• EPA Substance Registry System: Adenosine, N-benzoyl-5'-O-[bis(4-Methoxyphenyl)phenylMethyl]-2'-deoxy-2'-fluoro-(136834-21-4)

Safety Data

• Hazardous Substances Data: 136834-21-4(Hazardous Substances Data)

Usage

Description

Adenosine, N-benzoyl-5'-O-[bis(4-Methoxyphenyl)phenylMethyl]-2'-deoxy-2'-fluorois a complex organic compound with a unique molecular structure. It is a nucleoside building block derived from adenosine, a fundamental component of DNA and RNA. Adenosine, N-benzoyl-5'-O-[bis(4-Methoxyphenyl)phenylMethyl]-2'-deoxy-2'-fluorohas been modified with a benzoyl group, a bis(4-methoxyphenyl)phenylmethyl group, and a fluorine atom at the 2' position, which distinguishes it from the natural adenosine molecule. These modifications may enhance its properties and potential applications in various fields.

Uses

Used in Pharmaceutical Industry:
Adenosine, N-benzoyl-5'-O-[bis(4-Methoxyphenyl)phenylMethyl]-2'-deoxy-2'-fluorois used as a nucleoside building block for the preparation of 3'',4''-oxetane nucleosides. The application reason is its potential anti-viral properties, particularly towards Hepatitis C. The unique molecular structure of this compound may provide a new approach to developing effective treatments for this viral infection.
In addition to its use in the pharmaceutical industry, this compound may also have potential applications in other fields, such as:
1. Chemical Research:
As a complex organic molecule, Adenosine, N-benzoyl-5'-O-[bis(4-Methoxyphenyl)phenylMethyl]-2'-deoxy-2'-fluorocould be used in chemical research to study the effects of its unique structure on various chemical reactions and interactions with other molecules.
2. Material Science:
The unique properties of this compound, such as its modified adenosine structure and the presence of fluorine, may make it a candidate for the development of new materials with specific characteristics, such as improved stability or reactivity.
3. Diagnostics:
The modified adenosine structure could potentially be utilized in the development of diagnostic tools or tests, particularly in the field of molecular biology, where the detection and analysis of specific nucleosides and nucleotides are crucial.

Upstream product

• 40615-36-9 4,4'-dimethoxytrityl chloride 
• 136834-20-3 N-(9-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide 
• 79896-97-2 N6-benzoyl-9-β-D-arabinofuranosyladenine 
• 136834-18-9 N⁶-benzoyl-9-(3,5-di-O-tetrahydropyran-2-yl-β-D-arabinofuranosyl)adenine 
• 146954-64-5 N⁶-benzoyl-2'-deoxy-2'-fluoro-3',5'-di-O-tetrahydropyran-2-yladenosine 
• 136834-19-0 N⁶-benzoyl-9-<2-O-(trifluoromethylsulfonyl)-3,5-di-O-tetrahydropyran-2-yl-β-D-arabinofuranosyl>adenine 
• 20187-82-0 2'-fluorodeoxyadenosine 
• 98-88-4 benzoyl chloride 

Downstream Products

• 136834-22-5 N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-4-[2-cyanoethoxy-(diisopropylamino)phosphanyl]oxy-3-fluoro-tetrahydrofuran-2-yl]purin-6-yl]benzamide 
• 204633-61-4 Methanesulfonic acid (2R,3R,4R,5R)-5-(6-benzoylamino-purin-9-yl)-2-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-fluoro-tetrahydro-furan-3-yl ester 
• 20187-82-0 2'-fluorodeoxyadenosine 
• 110143-10-7 iodenosine 
• 204633-62-5 9-{(2R,5S)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-3-fluoro-2,5-dihydro-furan-2-yl}-9H-purin-6-ylamine 
• 204633-63-6 (2R,3R,4R,5R)-5-(6-Amino-purin-9-yl)-2-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-fluoro-tetrahydro-furan-3-ol 
• 1244763-23-2 C₄₄H₄₈FN₅O₆Si 
• 1337865-40-3 3'-O-[2-(4-azidomethylphenoxy)acetyl]-5'-O-(4',4''-dimethoxytriphenylmethyl)-N₆-benzoyl-2'-deoxy-2'-fluoroadenosine 

Relevant articles and documents

SALTS OF COMPOUNDS AND CRYSTALS THEREOF

The present invention provides crystals of (1R,3R,15E,28R,29R,30R,31R,34R,36R,39S,41R)-29,41-Difluoro-34,39-bis(sulfanyl)-2,33,35,38,40,42-hexaoxa-4,6,9,11,13,18,20,22,25,27-decaaza-34λ5,39λ5-diphosphaoctacyclo[28.6.4.13,36/sup

CYCLIC DI-NUCLEOTIDES AS STIMULATOR OF INTERFERON GENES MODULATORS

The present disclosure relates to a compound of formulae (I) or (II), or a pharmaceutically acceptable salt, a solvate, a hydrate thereof, a pharmaceutical composition comprising a compound of formulae (I) or (II), and use thereof, wherein various Markush

CYCLIC DI-NUCLEOTIDES COMPOUNDS FOR THE TREATMENT OF CANCER

Provided herein are compounds useful for the treatment of cancer.